Dr. Reza Arsanjani, MD, Mayo Clinic Arizona
Dr. Reza Arsanjani is a Professor of Medicine and Director of Cardiovascular Imaging at Mayo Clinic Arizona, where he has been on staff for the past decade and has led the imaging program for over seven years. He earned his medical degree from the University of Cincinnati College of Medicine, followed by residency in Internal Medicine and fellowship in Cardiology at the University of Arizona. He subsequently completed advanced cardiovascular imaging training at Cedars-Sinai Medical Center, where he developed a strong foundation in multimodality imaging and early applications of artificial intelligence in cardiology. Dr. Arsanjani’s research focuses on preventive cardiology, valvular heart disease, and the integration of artificial intelligence into cardiovascular imaging. He has authored numerous peer-reviewed publications (>330) and is actively involved in advancing innovative, AI-driven approaches to improve diagnostic accuracy, risk stratification, and patient outcomes in cardiovascular medicine.
Dr. David Kunkel, MD, AGAF, University of California, San Diego
Dr. David Kunkel is a Clinical Professor of Medicine at the University of California, San Diego, and a board-certified gastroenterologist specializing in gastrointestinal motility disorders. His work in amyloidosis centers on recognizing and treating digestive symptoms that can compromise nutrition and quality of life. He brings expertise in swallowing disorders, gastroparesis and bowel dysfunction to the care of patients with this complex disease. Dr. Kunkel contributes to NIH-funded research on new approaches to diagnosing and treating gastrointestinal motility disorders. He is a Fellow of the American Gastroenterological Association and has served on national gastroenterology society committees supporting education and clinical care.
Dr. Spencer Carter, MD, University of Utah
Dr. Carter was born in Boise, Idaho; he graduated with honors from the University of Notre Dame with a major in Science Business. He received his medical degree from the University of Washington. He then trained at the University of Texas Southwestern where he completed an internship and residency in Internal Medicine. He continued at UTSW, completing fellowships in Cardiovascular Disease and Advanced Heart Failure and Transplant Cardiology, winning several excellence in teaching awards. In addition to advanced heart failure, mechanical circulatory support, and transplant, Dr. Carter has clinical expertise in infiltrative cardiomyopathies and cardiac amyloidosis. His academic interest is in implementation science, quality improvement, and medical education. He serves as Medical Director of Heart Transplant, Cardiovascular Director for the Utah Amyloidosis program, and the Assistant Program Director for the Advanced Heart Failure and Transplant Fellowship program at the University of Utah.
Dr. Faizi Jamal, MD, City of Hope
Dr. Jamal is an associate clinical professor in the department of medicine at the City of Hope National Medical Center, an NCI-designated comprehensive cancer center in Los Angeles County. Dr. Jamal completed his medical degree at the University of California, Irvine, and then pursued internal medicine training and cardiology fellowship at Cedars-Sinai Medical Center. He served on faculty at Northwestern for several years, before returning to California in 2017. Since 2020, he has served as the Division Chief of Cardiology at City of Hope, as well as the director of their echo lab. He is the co-director of the Multidisciplinary Amyloidosis Clinic, founded in 2025. His research focuses on the intersection of echocardiography and cardiac amyloidosis. Dr. Jamal serves on two guideline panels within the American Society of Hematology, focusing on the diagnosis and treatment of AL amyloidosis. He also serves as a District Councilor and Trustee on the Board of Directors for the California Chapter of the ACC.